Your browser doesn't support javascript.
loading
Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial.
Kühnl, A; Cunningham, D; Counsell, N; Hawkes, E A; Qian, W; Smith, P; Chadwick, N; Lawrie, A; Mouncey, P; Jack, A; Pocock, C; Ardeshna, K M; Radford, J; McMillan, A; Davies, J; Turner, D; Kruger, A; Johnson, P W; Gambell, J; Rosenwald, A; Ott, G; Horn, H; Ziepert, M; Pfreundschuh, M; Linch, D.
Afiliação
  • Kühnl A; Department of Medicine, The Royal Marsden NHS Foundation Trust, London and Surrey.
  • Cunningham D; Department of Medicine, The Royal Marsden NHS Foundation Trust, London and Surrey.
  • Counsell N; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK.
  • Hawkes EA; Department of Medicine, The Royal Marsden NHS Foundation Trust, London and Surrey.
  • Qian W; Olivia-Newton John Cancer Research & Wellness Centre, Melbourne, Australia.
  • Smith P; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge.
  • Chadwick N; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK.
  • Lawrie A; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK.
  • Mouncey P; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK.
  • Jack A; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK.
  • Pocock C; HMDS, St James's Institute of Oncology, Leeds.
  • Ardeshna KM; East Kent Hospitals, Canterbury.
  • Radford J; Department of Hematology, University College London, London.
  • McMillan A; Mount Vernon Cancer Centre, Northwood.
  • Davies J; Department of Medical Oncology, University of Manchester and the Christie NHS Foundation Trust, Manchester.
  • Turner D; Department of Hematology, Nottingham City Hospital, Nottingham.
  • Kruger A; Western General Hospital, Edinburgh.
  • Johnson PW; Department of Hematology, Torbay Hospital, Torquay.
  • Gambell J; Royal Cornwall Hospital, Truro.
  • Rosenwald A; Cancer Research UK Center, University of Southampton, Southampton, UK.
  • Ott G; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK.
  • Horn H; Institute of Pathology, Würzburg University, Würzburg.
  • Ziepert M; Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart.
  • Pfreundschuh M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart and University of Tübingen, Stuttgart.
  • Linch D; Institute for Medical Informatics, Statistics, and Epidemiology, University of Leipzig, Leipzig.
Ann Oncol ; 28(7): 1540-1546, 2017 Jul 01.
Article em En | MEDLINE | ID: mdl-28398499
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Proteínas Proto-Oncogênicas c-myc / Linfoma Difuso de Grandes Células B / Proteínas Proto-Oncogênicas c-bcl-2 / Proteínas Proto-Oncogênicas c-bcl-6 Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 País/Região como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Proteínas Proto-Oncogênicas c-myc / Linfoma Difuso de Grandes Células B / Proteínas Proto-Oncogênicas c-bcl-2 / Proteínas Proto-Oncogênicas c-bcl-6 Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 País/Região como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article